UNITED THERAPEUTICS CORP
10-Q, EX-27, 2000-11-13
PHARMACEUTICAL PREPARATIONS
Previous: UNITED THERAPEUTICS CORP, 10-Q, 2000-11-13
Next: XIN NET CORP, SB-2/A, 2000-11-13



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED FINANCIAL STATEMENTS AS OF AND FOR THE THREE MONTHS ENDED SEPTEMBER
30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH UNAUDITED
FINANCIAL STATEMENTS CONTAINED IN THE FORM 10-Q.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                     224,287,827
<SECURITIES>                                14,256,455
<RECEIVABLES>                                  581,969
<ALLOWANCES>                                         0
<INVENTORY>                                  1,207,272
<CURRENT-ASSETS>                           240,835,378
<PP&E>                                       4,357,161
<DEPRECIATION>                               (438,543)
<TOTAL-ASSETS>                             252,441,245
<CURRENT-LIABILITIES>                        7,891,337
<BONDS>                                      1,762,778
                                0
                                          0
<COMMON>                                       201,846
<OTHER-SE>                                 242,571,461
<TOTAL-LIABILITY-AND-EQUITY>               252,441,245
<SALES>                                        353,891
<TOTAL-REVENUES>                               403,891
<CGS>                                          264,547
<TOTAL-COSTS>                               10,826,806
<OTHER-EXPENSES>                           (3,443,433)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              34,541
<INCOME-PRETAX>                            (7,014,023)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (7,014,023)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (7,014,023)
<EPS-BASIC>                                     (0.35)
<EPS-DILUTED>                                   (0.35)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission